INKON Life(300143)
Search documents
盈康生命(300143) - 关于完成工商变更登记并换发营业执照的公告
2025-06-26 08:00
证券代码:300143 证券简称:盈康生命 公告编号:2025-029 盈康生命科技股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 盈康生命科技股份有限公司(以下简称"公司")于 2025 年 6 月 18 日召开 的第六届董事会第十八次(临时)会议,审议通过了《关于聘任公司总经理和法 定代表人的议案》,同意聘任马安捷先生为公司总经理,任期自本次董事会审议 通过之日起至第六届董事会届满之日止,同时根据《公司章程》第八条"总经理 为公司的法定代表人",马安捷先生担任公司总经理后同时担任公司法定代表人。 具体内容详见公司于 2025 年 6 月 19 日在巨潮资讯网(http://www.cninfo.com.cn) 披露的《关于变更董事暨总经理、补选董事的公告》。 近日,公司完成了上述事宜的工商变更登记手续,并取得青岛市行政审批服 务局换发的《营业执照》。公司新换发的《营业执照》相关信息如下: 7、住所:山东省青岛市城阳区春阳路 37 号 8、经营范围:一般项目:股权投资;以自有资金从事投资活动;企业管理; ...
盈康生命: 关于变更董事暨总经理、补选董事的公告
Zheng Quan Zhi Xing· 2025-06-20 11:24
Group 1 - The resignation of Mr. Peng Wen, the company's director and general manager, and Mr. Ma Anjie, the deputy general manager, was announced due to personal reasons and work relocation respectively [1][2] - Mr. Peng Wen held 54,000 shares, accounting for 0.0072% of the total share capital, while Mr. Ma Anjie held 56,430 shares, accounting for 0.0075% [2] - The company plans to increase the number of board members from 7 to 9 to enhance decision-making capabilities and optimize governance structure [1][2] Group 2 - The company held a board meeting on June 18, 2025, to approve the nomination of Ms. Huang Wenyiao, Ms. Gong Wenwen, and Mr. Ma Anjie as candidates for non-independent directors [1][3] - Mr. Ma Anjie was appointed as the new general manager and legal representative of the company, with his term starting from the board's approval date [3][9] - The board authorized management to handle the necessary changes in legal representation and registration with the relevant authorities [3]
盈康生命: 选聘会计师事务所专项制度(2025年6月)
Zheng Quan Zhi Xing· 2025-06-20 11:23
Core Viewpoint - The document outlines the regulations and procedures for selecting accounting firms at Yingkang Life Technology Co., Ltd, emphasizing the importance of maintaining shareholder rights and ensuring the quality of financial audits [1][2]. Group 1: General Principles - The selection of accounting firms must adhere to relevant laws and regulations, including the Management Measures for the Selection of Accounting Firms by State-owned Enterprises and Listed Companies [2]. - The selection process should ensure fairness and impartiality [2]. Group 2: Responsibilities of the Audit Committee - The Audit Committee is responsible for proposing the selection of accounting firms and supervising their audit work [3]. - The committee must evaluate the qualifications of the accounting firms and submit a report on their performance at least once a year [3][4]. Group 3: Conditions for Selected Accounting Firms - Selected accounting firms must possess independent qualifications and meet the requirements set by regulatory authorities [5]. - They should have a good reputation and a record of quality in their auditing practices [5]. Group 4: Selection Methods - The company may use competitive negotiation, public bidding, or invitation bidding to select accounting firms [6]. - The selection process must be transparent, with results publicly announced [6]. Group 5: Selection Procedures - The general procedure for selecting accounting firms includes qualification review, board approval, and signing an audit agreement [7][8]. - The Audit Committee must evaluate the performance of the accounting firms annually and can propose reappointment if the performance is satisfactory [8]. Group 6: Special Provisions for Reappointment - The Audit Committee should evaluate the performance of the accounting firm before proposing reappointment [9]. - If the firm is to be replaced, the reasons must be disclosed in detail during the shareholders' meeting [9]. Group 7: Supervision and Penalties - The Audit Committee is responsible for supervising the selection process and ensuring compliance with laws and regulations [10]. - Violations of the selection regulations can lead to penalties, including the dismissal of the accounting firm and disciplinary actions against responsible personnel [10][11].
盈康生命: 防范控股股东及关联方资金占用管理办法(2025年6月)
Zheng Quan Zhi Xing· 2025-06-20 11:23
Core Viewpoint - The company has established a comprehensive management approach to prevent the controlling shareholder and related parties from occupying its funds, ensuring compliance with relevant laws and regulations [1][2][4]. Group 1: General Principles - The management measures aim to create a long-term mechanism to prevent fund occupation by the controlling shareholder and related parties, in accordance with various legal frameworks [1]. - Fund occupation is categorized into operational and non-operational types, with specific definitions provided for each [1][2]. Group 2: Specific Principles for Prevention - The company must strictly limit the operational fund transactions with the controlling shareholder and related parties, prohibiting the provision of funds through various indirect means [2][3]. - The controlling shareholder and related parties are explicitly prohibited from occupying company funds through various methods, including requesting the company to cover expenses or debts [2][4]. Group 3: Responsibilities and Measures - The company’s board of directors and senior management are responsible for safeguarding the company’s funds and assets, with the chairman being the primary responsible person for preventing fund occupation [4][5]. - The audit department is tasked with monitoring compliance with internal controls and operational activities to ensure proper implementation of these measures [5]. Group 4: Accountability and Penalties - The board of directors can demand compensation from the controlling shareholder if their actions harm the company or other shareholders, and can initiate judicial freezing of shares if necessary [6]. - Any violations leading to fund occupation or improper guarantees will result in administrative and legal consequences for responsible individuals [6].
盈康生命: 董事会议事规则(2025年6月)
Zheng Quan Zhi Xing· 2025-06-20 11:22
General Principles - The purpose of the rules is to standardize the decision-making process of the board of directors and improve corporate governance structure [1] - The rules are based on relevant laws and regulations including the Company Law and Securities Law of the People's Republic of China [1] Composition and Powers of the Board - The board consists of 9 directors, including 3 independent directors and 1 employee representative [2] - The board has the authority to convene shareholder meetings, execute resolutions, decide on business plans, and manage internal structures [2][3] Decision-Making Procedures - The board must establish strict review and decision-making procedures for significant transactions, requiring expert evaluations for major investments [2][3] - Transactions meeting certain thresholds must be submitted for board review and timely disclosure [3][4] Independent Directors - Independent directors are required to hold special meetings to discuss matters such as related party transactions and changes in commitments [5][6] - They have the authority to independently hire intermediaries for audits and consultations [6] Chairman's Responsibilities - The chairman is responsible for the operation of the board and ensuring effective communication with shareholders [7][8] - The chairman has specific powers including presiding over meetings and making emergency decisions [7] Board Committees - The board has established specialized committees including Strategy and ESG, Nomination, Audit, and Compensation Committees [12][18] - Each committee has defined responsibilities and must report to the board for approval [12][18] Meeting Procedures - Board meetings require a majority of directors to be present, with specific rules for related party transactions [20][21] - Minutes of meetings must be recorded, detailing attendance and decisions made [21] Financial and Operational Support - The company provides necessary resources for the board to fulfill its responsibilities [23] - A special fund may be established for board-related expenses, subject to shareholder approval [23] Director Accountability - Directors are accountable for their decisions, with provisions for rewards for outstanding contributions and penalties for violations [47][48] - The rules stipulate that directors must disclose dissenting opinions to avoid liability [48]
盈康生命: 董事、高级管理人员持股管理制度(2025年6月)
Zheng Quan Zhi Xing· 2025-06-20 11:22
General Provisions - The purpose of the management system is to strengthen the management of shares held by the company's directors and senior management, and to clarify management procedures based on relevant laws and regulations [1][2] - Directors and senior management are prohibited from engaging in margin trading with the company's stock [2][5] Information Reporting Regulations - The company secretary is responsible for managing the identity and shareholding data of directors and senior management, and must report personal information to the Shenzhen Stock Exchange within specified timeframes [4][5] - Directors and senior management must ensure the accuracy and timeliness of the information submitted to the Shenzhen Stock Exchange [6] Trading Regulations - Directors and senior management must notify the company secretary in writing before trading the company's stock, and the securities department must verify compliance with disclosure and legal requirements [9][10] - A reduction plan must be reported to the board at least 15 trading days before any share transfer, detailing the number of shares, reasons, and methods for reduction [7][10] Prohibited Trading Periods - Directors and senior management are prohibited from transferring shares under certain conditions, such as within one year of the company's stock listing or within six months after leaving the company [12][13] - Trading is also restricted during specific periods, such as before the announcement of annual or quarterly reports [13] Penalties and Responsibilities - Violations of the trading regulations may result in administrative or criminal liability, and the company must cooperate with relevant authorities [26][27] - Shareholders holding more than 5% of the company's shares must comply with relevant regulations regarding share trading [27] Additional Provisions - The company board holds the interpretation rights of this management system, which takes effect upon approval by the board [29][30]
盈康生命: 投资者关系管理制度(2025年6月)
Zheng Quan Zhi Xing· 2025-06-20 11:22
Core Viewpoint - The company establishes an investor relations management system to enhance communication with investors, promote understanding and recognition of the company, and ultimately maximize corporate value and shareholder rights [2][4]. Group 1: Principles of Investor Relations Management - Compliance Principle: The company must conduct investor relations management in accordance with legal obligations and industry standards [3]. - Equality Principle: The company should treat all investors equally, especially facilitating participation for small and medium investors [3]. - Proactivity Principle: The company should actively engage in investor relations activities and respond to investor feedback [3]. - Honesty and Integrity Principle: The company must emphasize integrity and responsibility in its investor relations activities [3]. Group 2: Objectives of Investor Relations Management - Foster a positive relationship between the company and investors to enhance understanding [4]. - Establish a stable and high-quality investor base for long-term market support [4]. - Create a corporate culture that respects and serves investors [4]. - Promote the dual goals of maximizing overall company interests and increasing shareholder wealth [4]. - Improve transparency in information disclosure and enhance corporate governance [4]. Group 3: Responsibilities and Activities - The company is responsible for drafting the investor relations management system and establishing a working mechanism [5]. - Organize communication activities with investors and handle inquiries, complaints, and suggestions [5]. - Maintain and manage channels for investor relations and ensure investors can exercise their rights [5]. - Conduct activities that improve investor relations, including setting up a dedicated section on the company website for investor information [5]. Group 4: Communication Methods - The company should utilize multiple channels and platforms for investor relations, including the official website, new media, and direct communication methods like meetings and roadshows [15]. - Establish a mechanism for communicating significant events with investors while adhering to information disclosure rules [15][16]. - Ensure that all communications are transparent and do not involve undisclosed significant information [16]. Group 5: Internal Management and Training - The company’s board secretary is responsible for coordinating investor relations management activities [10]. - The securities department handles daily investor relations tasks and collects relevant information from various departments [12]. - Training for employees involved in investor relations is essential to ensure they possess the necessary skills and knowledge [6].
盈康生命: 媒体来访和投资者调研接待工作管理办法(2025年6月)
Zheng Quan Zhi Xing· 2025-06-20 11:22
盈康生命科技股份有限公司 盈康生命科技股份有限公司 媒体来访和投资者调研接待工作管理办法 (2025 年 6 月) 第一章 总则 第一条 为贯彻证券市场公开、公平、公正原则,规范盈康生命科技股份有限 公司(以下简称"公司")对外接待行为,加强公司对外接待及与外界的交流和沟 通,提高公司投资者关系管理水平,根据《中华人民共和国公司法》 《中华人民共 和国证券法》《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监 管指引第 2 号——创业板上市公司规范运作》等法律法规和规范性文件以及公司 章程的规定,结合公司实际,制定本办法。 第二条 本规定所述的投资者调研接待工作,是指公司通过接受投资者、媒体、 证券机构的调研、一对一沟通、一对多沟通、现场参观、分析师会议、路演和业 绩说明会、新闻采访等活动,增进资本市场对公司的了解和认同的工作。 第三条 本规定所称重大信息是指对公司股票及其衍生品种交易价格可能或 已经产生较大影响的信息,包括下列信息: (一)与公司业绩、利润分配等事项有关的信息,如财务业绩、盈利预测、 利润分配和资本公积金转增股本等; (二)与公司收购兼并、资产重组等事项有关的信息; (三)与公司股 ...
盈康生命: 董事会薪酬与考核委员会工作细则(2025年6月)
Zheng Quan Zhi Xing· 2025-06-20 11:22
Core Points - The article outlines the establishment and operational guidelines of the Compensation and Assessment Committee of Yinkang Life Science Technology Co., Ltd. to enhance the governance structure and management of director and senior management compensation [1][3][4] Group 1: General Provisions - The Compensation and Assessment Committee is a specialized committee under the board of directors responsible for setting assessment standards and compensation policies for directors and senior management [1][3] - The committee consists of three directors, including two independent directors, and is chaired by an independent director [3][4] Group 2: Responsibilities and Authority - The committee's main responsibilities include formulating compensation plans based on management roles, reviewing performance evaluations, and supervising the execution of compensation policies [3][8] - The committee must submit compensation plans for directors to the board for approval and subsequently to the shareholders' meeting for ratification [4][5] Group 3: Decision-Making Procedures - The committee is required to prepare for decision-making by gathering relevant financial and operational data, including performance metrics and management responsibilities [5][6] - Performance evaluations for directors and senior management involve self-assessments and adherence to established performance standards [6][7] Group 4: Meeting Rules - The committee holds regular meetings at least once a year and can convene temporary meetings as needed, with specific notification requirements [6][7] - Decisions require the presence of at least two-thirds of the committee members, and voting is conducted by a show of hands or through written communication for temporary meetings [7][8] Group 5: Miscellaneous Provisions - The guidelines specify that all meetings must be documented, and members are bound by confidentiality regarding discussed matters [8][8] - The guidelines take effect upon approval by the board and are subject to relevant national laws and regulations [8]
盈康生命: 内幕信息知情人登记制度(2025年6月)
Zheng Quan Zhi Xing· 2025-06-20 11:22
盈康生命科技股份有限公司 盈康生命科技股份有限公司 内幕信息知情人登记制度 (2025 年 6 月) 第一章 总则 第一条 为进一步规范盈康生命科技股份有限公司(以下简称"公司")内幕 信息管理行为,加强内幕信息保密工作,维护公司信息披露的公平、公正、公开 原则,根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人 民共和国证券法》(以下简称"《证券法》")、《深圳证券交易所创业板股票 上市规则》(以下简称"《创业板上市规则》")、《深圳证券交易所上市公司 自律监管指引第 2 号——创业板上市公司规范运作》(以下简称"《创业板上市 公司规范运作》")、《上市公司信息披露管理办法》以及《盈康生命科技股份 有限公司章程》(以下简称"《公司章程》")的有关规定,特制定本制度。 第二条 内幕信息的管理工作由董事会负责,董事长为主要责任人,董事会秘 书组织实施。证券部是公司信息披露管理、投资者关系管理、内幕信息登记备案 的日常办事机构,并负责公司内幕信息的监管工作。 第三条 未经董事会批准同意,在内幕消息依法披露前,公司任何部门和个人 或其他获取内幕消息的人不得公开或向外界透露、泄露、报道、传送有关公司内 ...